Aimei Health Technology Co., Ltd (NASDAQ:AFJK – Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 1,200 shares, an increase of 20.0% from the November 15th total of 1,000 shares. Based on an average daily volume of 36,500 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are sold short.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. Glazer Capital LLC boosted its position in shares of Aimei Health Technology by 3.4% during the third quarter. Glazer Capital LLC now owns 608,670 shares of the company’s stock valued at $6,379,000 after buying an additional 19,896 shares during the period. Wolverine Asset Management LLC boosted its holdings in Aimei Health Technology by 8.6% during the 3rd quarter. Wolverine Asset Management LLC now owns 539,039 shares of the company’s stock valued at $5,649,000 after acquiring an additional 42,843 shares during the period. Mizuho Securities USA LLC grew its position in Aimei Health Technology by 60.7% in the 3rd quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company’s stock valued at $4,627,000 after acquiring an additional 167,223 shares during the last quarter. Shaolin Capital Management LLC grew its position in Aimei Health Technology by 33.3% in the 2nd quarter. Shaolin Capital Management LLC now owns 400,000 shares of the company’s stock valued at $4,140,000 after acquiring an additional 100,000 shares during the last quarter. Finally, Rivernorth Capital Management LLC increased its stake in Aimei Health Technology by 9.1% in the third quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company’s stock worth $1,811,000 after purchasing an additional 14,391 shares during the period. Institutional investors own 45.58% of the company’s stock.
Aimei Health Technology Price Performance
NASDAQ AFJK opened at $10.62 on Monday. The business’s 50 day moving average price is $10.57 and its 200-day moving average price is $10.46. Aimei Health Technology has a fifty-two week low of $10.15 and a fifty-two week high of $10.69.
About Aimei Health Technology
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Further Reading
- Five stocks we like better than Aimei Health Technology
- Expert Stock Trading Psychology Tips
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Investing in the High PE Growth Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The How and Why of Investing in Gold Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.